Vida’s clinical obesity program offers qualitative and quantitative results, with and without GLP-1s, but many are unaware of how those outcomes are driven, and how they can see success through Vida’s solutions.
Vida’s clinical obesity program offers qualitative and quantitative results, with and without GLP-1s, but many are unaware of how those outcomes are driven, and how they can see success through Vida’s solutions.
Watch the on-demand webinar that takes a deep dive into how new pricing for GLP-1s is reshaping access and raising questions about how to design sustainable benefits.
For too long, culture has framed this transition as the beginning of invisibility or loss. In reality, it’s an opportunity to take up space, rebuild strength, and redefine what thriving looks like in midlife. It’s just a matter of knowing how.
Plan sponsors don’t just need to save money today; they need to ensure that those savings don’t backfire tomorrow in the form of worse outcomes and higher costs.